tiprankstipranks
Trending News
More News >
Faes Farma (ES:FAE)
:FAE
Advertisement

Faes Farma (FAE) Price & Analysis

Compare
18 Followers

FAE Stock Chart & Stats

€4.48
€0.00(0.00%)
At close: 4:00 PM EST
€4.48
€0.00(0.00%)

Faes Farma News

FAE FAQ

What was Faes Farma’s price range in the past 12 months?
Faes Farma lowest stock price was €3.27 and its highest was €4.73 in the past 12 months.
    What is Faes Farma’s market cap?
    Faes Farma’s market cap is €1.37B.
      When is Faes Farma’s upcoming earnings report date?
      Faes Farma’s upcoming earnings report date is Feb 27, 2026 which is in 110 days.
        How were Faes Farma’s earnings last quarter?
        Currently, no data Available
        Is Faes Farma overvalued?
        According to Wall Street analysts Faes Farma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Faes Farma pay dividends?
          Faes Farma pays a Semiannually dividend of €0.138 which represents an annual dividend yield of 4.06%. See more information on Faes Farma dividends here
            What is Faes Farma’s EPS estimate?
            Faes Farma’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Faes Farma have?
            Faes Farma has 316,223,940 shares outstanding.
              What happened to Faes Farma’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Faes Farma?
              Currently, no hedge funds are holding shares in ES:FAE

              Faes Farma Stock Smart Score

              4
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              27.62%
              12-Months-Change

              Fundamentals

              Return on Equity
              14.89%
              Trailing 12-Months
              Asset Growth
              19.41%
              Trailing 12-Months

              Company Description

              Faes Farma

              Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.

              Faes Farma (FAE) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Almirall
              Grifols
              LABORATORIO REIG JOFRE
              Laboratorios Farmaceuticos Rovi
              Pharma Mar SA

              Options Prices

              Currently, No data available
              ---
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis